Next report date
Report period
H1 2024
EPS estimate
—
Revenue estimate
—
−0.0365EUR
−5.88 MEUR
17.63 KEUR
70.91 M
About TRELLUS HEALTH PLC ORD GBP0.0006
Sector
Industry
CEO
Marla C. Dubinsky
Website
Headquarters
Cardiff
Founded
2020
ISIN
GB00BNNFM402
FIGI
BBG011J0H9R8
Trellus Health Plc engages in the provision of digital chronic condition management solutions for employers and health plans. It utilizes the scientifically validated GRITT resilience-based methodology and a proprietary HIPAA-compliant technology platform called TrellusElevate, to coordinate and deliver care remotely via telemedicine. The company was founded by Marla C. Dubinsky and Laurie Keefer on July 15, 2020 and is headquartered in Cardiff, the United Kingdom.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange TRELLUS HEALTH LS -,0006 stocks are traded under the ticker 85Q.
TRELLUS HEALTH LS -,0006 is going to release the next earnings report on Sep 27, 2024. Keep track of upcoming events with our Earnings Calendar.
Yes, you can track TRELLUS HEALTH LS -,0006 financials in yearly and quarterly reports right on TradingView.
85Q net income for the last quarter is −2.55 M EUR, while the quarter before that showed −3.37 M EUR of net income which accounts for 24.20% change. Track more TRELLUS HEALTH LS -,0006 financial stats to get the full picture.
No, 85Q doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 85Q shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade TRELLUS HEALTH LS -,0006 stock right from TradingView charts — choose your broker and connect to your account.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. TRELLUS HEALTH LS -,0006 EBITDA is −5.43 M EUR, and current EBITDA margin is −30.77 K%. See more stats in TRELLUS HEALTH LS -,0006 financial statements.